SE452317B - Analogiforfarande for framstellning av terapeutiskt aktiva, nya di-n-propyl-metylamin-derivat - Google Patents

Analogiforfarande for framstellning av terapeutiskt aktiva, nya di-n-propyl-metylamin-derivat

Info

Publication number
SE452317B
SE452317B SE7706448A SE7706448A SE452317B SE 452317 B SE452317 B SE 452317B SE 7706448 A SE7706448 A SE 7706448A SE 7706448 A SE7706448 A SE 7706448A SE 452317 B SE452317 B SE 452317B
Authority
SE
Sweden
Prior art keywords
propyl
preparation
new
therapeutically active
analogy procedure
Prior art date
Application number
SE7706448A
Other languages
English (en)
Other versions
SE7706448L (sv
Inventor
C Pigerol
P Eymard
M Broll
J-C Vernieres
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SE7706448L publication Critical patent/SE7706448L/sv
Publication of SE452317B publication Critical patent/SE452317B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7706448A 1976-06-03 1977-06-02 Analogiforfarande for framstellning av terapeutiskt aktiva, nya di-n-propyl-metylamin-derivat SE452317B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE842528 1976-06-03

Publications (2)

Publication Number Publication Date
SE7706448L SE7706448L (sv) 1977-12-04
SE452317B true SE452317B (sv) 1987-11-23

Family

ID=3861370

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7706448A SE452317B (sv) 1976-06-03 1977-06-02 Analogiforfarande for framstellning av terapeutiskt aktiva, nya di-n-propyl-metylamin-derivat
SE8206445A SE452763B (sv) 1976-06-03 1982-11-12 Analogiforfarande for framstellning av terapeutiskt aktiva di-n-propyl-metylaminderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8206445A SE452763B (sv) 1976-06-03 1982-11-12 Analogiforfarande for framstellning av terapeutiskt aktiva di-n-propyl-metylaminderivat

Country Status (17)

Country Link
JP (1) JPS6039261B2 (sv)
AR (4) AR213646A1 (sv)
AT (1) AT352088B (sv)
AU (1) AU511705B2 (sv)
DK (1) DK146063C (sv)
ES (2) ES459466A1 (sv)
FI (1) FI63015C (sv)
FR (2) FR2374901A1 (sv)
GR (1) GR61148B (sv)
MX (1) MX4778E (sv)
NL (1) NL7706052A (sv)
NO (1) NO145337C (sv)
NZ (1) NZ184161A (sv)
PT (1) PT66623B (sv)
SE (2) SE452317B (sv)
YU (1) YU129577A (sv)
ZA (1) ZA773151B (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE815273A (fr) * 1974-05-20 1974-11-20 Derives actifs de methylamine
BE842528R (fr) * 1976-06-03 1976-12-03 Derives actifs de methylamine, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions

Also Published As

Publication number Publication date
YU129577A (en) 1983-01-21
JPS52148006A (en) 1977-12-08
SE8206445L (sv) 1982-11-12
PT66623A (en) 1977-07-01
AU511705B2 (en) 1980-09-04
ZA773151B (en) 1978-04-26
AR215053A1 (es) 1979-08-31
SE452763B (sv) 1987-12-14
PT66623B (en) 1978-11-07
FI63015B (fi) 1982-12-31
DK244677A (da) 1977-12-04
FI63015C (fi) 1983-04-11
DK146063C (da) 1983-11-14
MX4778E (es) 1982-09-15
NO145337C (no) 1982-03-03
AU2556177A (en) 1978-11-30
AR215175A1 (es) 1979-09-14
NO145337B (no) 1981-11-23
SE8206445D0 (sv) 1982-11-12
DK146063B (da) 1983-06-20
NZ184161A (en) 1980-10-08
FR2374901B1 (sv) 1981-04-17
AR215052A1 (es) 1979-08-31
JPS6039261B2 (ja) 1985-09-05
FR2372795A1 (fr) 1978-06-30
GR61148B (en) 1978-09-27
FR2374901A1 (fr) 1978-07-21
SE7706448L (sv) 1977-12-04
NO771941L (no) 1977-12-06
NL7706052A (nl) 1977-12-06
FR2372795B1 (sv) 1983-08-12
AR213646A1 (es) 1979-02-28
FI771780A (sv) 1977-12-04
ES459466A1 (es) 1978-08-16
ES470379A1 (es) 1979-10-16
AT352088B (de) 1979-08-27
ATA395877A (de) 1979-02-15

Similar Documents

Publication Publication Date Title
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO146396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO148416C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO147913C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO142625C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO149388C (no) Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
SE428688B (sv) Forfarande for framstellning av nya antidiabetiskt aktiva isooxazolderivat
NO149208C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzodiazepiner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7706448-3

Effective date: 19890426

Format of ref document f/p: F